Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 double-blind randomized trial of pamiparib maintenance vs placebo in advanced gastric cancer after platinum chemotherapy
jRCT2080225173Phase 2Completed
- Sponsor
- BeiGene
- Start
- Apr 2020
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma comparing Pamiparib maintenance with Placebo maintenance (2 arms). Started Apr 2020; status: completed.
02
Drugs
pamiparib
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on jRCT2080225173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225173.